Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Other neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Carcinoma, Ovarian Epithelial 9Breast Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Myeloproliferative Disorders 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Congenital Abnormalities 5Burkitt Lymphoma 5Testicular Neoplasms 4Sezary Syndrome 4Primary Myelofibrosis 4Pdgfra-Associated Chronic Eosinophilic Leukemia 4Ovarian Neoplasms 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Leukemia, Neutrophilic, Chronic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Hairy Cell 4

Interventions

Colposcopy 18Imiquimod 14Conization 12Papillomavirus Vaccines 9Vaccines 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Papanicolaou Test 5Human Papillomavirus DNA Tests 5Blood Specimen Collection 5Watchful Waiting 4GX-188 vaccine 4Surveys and Questionnaires 3Cisplatin 3VGX-3100 2Transurethral Resection of Prostate 2Topotecan 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Indomethacin 2Immunohistochemistry 2Human Papillomavirus Recombinant Vaccine nonavalent 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × Flow Cytometry × Gynecologic × Clear all
NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡